Dendritic Cells Expressing Plasmacytoid Marker PDCA-1 Are Trojan Horses during Toxoplasma gondii Infection

被引:97
作者
Bierly, Allison L. [1 ]
Shufesky, William J. [2 ,3 ]
Sukhumavasi, Woraporn [1 ]
Morelli, Adrian E. [2 ,3 ]
Denkers, Eric Y. [1 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA
[2] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Dept Surg, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA
关键词
D O I
10.4049/jimmunol.181.12.8485
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmacytoid dendritic cells (pDCs) play a key role in the innate immune response to viral infection, due largely to their ability to produce large quantities of type I IFNs. These cells are also notable for their ability to differentiate into conventional dendritic cells after appropriate stimulation. Here, we show that a splenic population of murine CD11c(+) cells expressing pDC markers Gr-1, B220, and PDCA-1 is preferentially parasitized after infection with the virulent RH strain of Toxoplasma gondii. Although these markers are closely associated with pDCs, the population we identified was unusual because the cells express CD11b and higher than expected levels of CD11c. By adoptive transfer of CD45.1-positive cells into CD45.2 congenic mice, we show that CD11c(+)Gr-1(+) cells migrate from the peritoneal cavity to the spleen. During infection, these cells accumulate in the marginal zone region. Recruitment of infected CD11c(+)Gr-1(+) cells to the spleen is partially dependent upon signaling through chemokine receptor CCR2. Intracellular cytokine staining demonstrates that infected, but not noninfected, splenic CD11c(+)Gr-1(+) dendritic cells are suppressed in their ability to respond to ex vivo TLR stimulation. We hypothesize that Toxoplasma exploits pDCs as Trojan horses, targeting them for early infection, suppressing their cytokine effector function, and using them for dissemination within the host. The Journal of Immunology, 2008, 181: 8485-8491.
引用
收藏
页码:8485 / 8491
页数:7
相关论文
共 47 条
[1]   CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells [J].
Aliberti, J ;
Sousa, CRE ;
Schito, M ;
Hieny, S ;
Wells, T ;
Huffnagle, GB ;
Sher, A .
NATURE IMMUNOLOGY, 2000, 1 (01) :83-87
[2]   Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody [J].
Asselin-Paturel, C ;
Brizard, G ;
Pin, JJ ;
Brière, F ;
Trinchieri, G .
JOURNAL OF IMMUNOLOGY, 2003, 171 (12) :6466-6477
[3]   Type I interferon dependence of plasmacytoid dendritic cell activation and migration [J].
Asselin-Paturel, C ;
Brizard, G ;
Chemin, K ;
Boonstra, A ;
O'Garra, A ;
Vicari, A ;
Trinchieri, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07) :1157-1167
[4]   The IFN gamma receptor: A paradigm for cytokine receptor signaling [J].
Bach, EA ;
Aguet, M ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :563-&
[5]   Cutting edge:: IL-10-Independent STAT3 activation by toxoplasma gondii mediates suppression of IL-12 and TNF-α in host macrophages [J].
Butcher, BA ;
Kim, L ;
Panopoulos, AD ;
Watowich, SS ;
Murray, P ;
Denkers, EY .
JOURNAL OF IMMUNOLOGY, 2005, 174 (06) :3148-3152
[6]   Mechanism of entry determines the ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production [J].
Butcher, BA ;
Denkers, EY .
INFECTION AND IMMUNITY, 2002, 70 (09) :5216-5224
[7]   Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB [J].
Butcher, BA ;
Kim, L ;
Johnson, PF ;
Denkers, EY .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :2193-2201
[8]   Plasmacytoid dendritic cells in immunity [J].
Colonna, M ;
Trinchieri, G ;
Liu, YJ .
NATURE IMMUNOLOGY, 2004, 5 (12) :1219-1226
[9]   CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain [J].
Courret, N ;
Darche, S ;
Sonigo, P ;
Milon, G ;
Buzoni-Gâtel, D ;
Tardieux, I .
BLOOD, 2006, 107 (01) :309-316
[10]  
DEHIERREGROCKIE.F, 2007, J IMMUNOL, V179, P1129